2021
DOI: 10.1093/ehjacc/zuab032
|View full text |Cite
|
Sign up to set email alerts
|

Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes

Abstract: Aims This study aims to evaluate if pre-hospital heparin administration by paramedics is safe and improves clinical outcomes. Methods and results Using the multicentre Victorian Cardiac Outcomes Registry, linked with state-wide ambulance records, we identified consecutive patients undergoing primary percutaneous coronary intervention for STEMI between January 2014 and December 2018. Information on thrombolysis in myocardial i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 29 publications
1
11
0
1
Order By: Relevance
“…In STEMI patients-in whom coronary artery occlusion is likely-pre-hospital administration of heparin did not affect clinical outcomes in prior analyses. Heparin use led to fewer coronary artery occlusions, but major adverse cardiac events or 30 day survival were not affected [35][36][37]. In accordance, the current analysis did not reveal clinically significant differences between loaded and non-pretreated STEMI group.…”
Section: Undertreatment Of Stemisupporting
confidence: 83%
“…In STEMI patients-in whom coronary artery occlusion is likely-pre-hospital administration of heparin did not affect clinical outcomes in prior analyses. Heparin use led to fewer coronary artery occlusions, but major adverse cardiac events or 30 day survival were not affected [35][36][37]. In accordance, the current analysis did not reveal clinically significant differences between loaded and non-pretreated STEMI group.…”
Section: Undertreatment Of Stemisupporting
confidence: 83%
“… 19 , 22 , 23 Additionally, over the study period, prehospital care of ST-elevated myocardial infarction has evolved, with EMS scope of practice expanding to allow for the administration of fibrinolytic therapy in patients with an estimated time greater than 120 minutes to percutaneous reperfusion, which may reduce symptom-to-reperfusion times and potentially contribute to a reduction in cardiogenic shock incidence. 24 , 25 Finally, in Victoria, our group has shown a temporal reduction in the adjusted annual incidence of out-of-hospital cardiac arrest due to cardiac etiology, which likely further contributed to the observed reduction in incidence of shock over the study period. 26 …”
Section: Discussionmentioning
confidence: 71%
“…This improvement is likely because of several factors, including public health initiatives to reduce modifiable risk factors for cardiovascular disease and effective local education campaigns promoting community members to seek early medical attention with the onset of symptoms suggestive of myocardial infarction . Additionally, over the study period, prehospital care of ST-elevated myocardial infarction has evolved, with EMS scope of practice expanding to allow for the administration of fibrinolytic therapy in patients with an estimated time greater than 120 minutes to percutaneous reperfusion, which may reduce symptom-to-reperfusion times and potentially contribute to a reduction in cardiogenic shock incidence . Finally, in Victoria, our group has shown a temporal reduction in the adjusted annual incidence of out-of-hospital cardiac arrest due to cardiac etiology, which likely further contributed to the observed reduction in incidence of shock over the study period …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the widespread use of UFH during PCI, robust evidence is scarce on the benefits of administering anticoagulation at earlier stages within a PCI context. To date, only four small randomised controlled trials (RCTs) (2,(5)(6)(7) and several observational studies (8)(9)(10)(11)(12)(13)(14)(15)(16)(17) with varying results on patient-relevant outcomes have investigated UFH pretreatment in patients with STEMI undergoing PCI. Additionally, the evidence on mortality outcomes remains inconclusive.…”
Section: Introductionmentioning
confidence: 99%